Active ingredientOxybuprocaine HydrochlorideCat. No. P-O068-001CAS 5987-82-6Family · Pharmaceutical analytical standards
Oxybuprocaine
An ester-type local anaesthetic, also known as benoxinate, first described in 1951: as eye drops it numbs the surface of the eye for examinations such as tonometry and for removing small foreign bodies. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?It works fast: the cornea is numb within 30-50 seconds and stays so for 10 to 30 minutes. It is also used to numb the nose and throat before examinations such as bronchoscopy.
Go to the active ingredient →Active ingredientOxybuprocaine HydrochlorideCat. No. P-O068-001CAS 5987-82-6
Pharmacopoeial impurityOxybuprocaine EP Impurity BCat. No. P-O068-002CAS 23442-22-0
Pharmacopoeial impurityOxybuprocaine EP Impurity CCat. No. P-O068-003CAS 2374-03-0
ImpurityOxybuprocaine Impurity 1 HydrochlorideCat. No. P-O068-004CAS 860693-48-7
Impurity3-Butoxy-4-nitrobenzoic acidCat. No. P-O068-005CAS 72101-53-2
ImpurityMethyl 3-butoxy-4-nitrobenzoateCat. No. P-O068-006CAS 1309686-09-6
ImpurityMethyl 4-amino-3-butoxybenzoateCat. No. P-O068-007CAS 1096863-52-3
ImpurityOxybuprocaine N-Oxide DihydrochlorideCat. No. P-O068-008CAS 2727060-44-6No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceOxybuprocaine hydrochloride CRSEDQM code O0270000Family OxybuprocaineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.